超越生殖细胞瘤:从单一中心的经验中专注于莱迪格细胞瘤
Rosario Leonardi1, Alessandro D'Angelo2, Guglielmo Mantica3
1Department of Medicine and Surgery, University KORE of Enna; Casa di Cura Musumeci GECAS, Gravina di Catania (CT). leonardi.r@tiscali.it.
概括
莱迪格细胞瘤 (LCTs) 是一种罕见的丸瘤. 这一案例系列展示了LCT存在的异质性,强调准确的诊断和个性化治疗,以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 内分泌学 在内分泌学.
背景情况:
- 莱迪格细胞瘤 (LCTs) 是一种罕见的丸瘤.
- LCT通常是偶尔出现的,或者伴有荷尔蒙症状.
- 存在恶性潜在的存在,由于缺乏指导方针,这给诊断带来了挑战.
研究的目的:
- 分析LCT病例的临床,生化,放射,手术和病理数据.
- 突出LCTs的诊断和管理策略.
主要方法:
- 四个经组织学确认的LCT病例 (2000-2024) 的回顾性分析.
- 收集的数据包括临床表现,成像,荷尔蒙形状和病理学.
- 所有患者都接受了激进的 inguinal orchiectomy.
主要成果:
- 呈现方式各不相同,包括丸胀,不孕症或偶然发现.
- 瘤大小在1.8至3.5厘米之间.
- 所有确认的良性LCT没有高风险特征;不需要辅助治疗;在随访时所有无疾病.
结论:
- LCT表现异质,需要准确的诊断和个性化治疗.
- 多学科管理,标准化协议和及时成像是至关重要的.
- 提高认识和及时诊断可以防止过度治疗,并改善患者的治疗结果.
更多相关视频
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
8.6K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...